← Back
$AXSM All transactions

Axsome Therapeutics, Inc.

M 10b5-1 Plan

$ Value

$73K

Shares

15,000

Price

$5

Filed

Sep 17

Insider

Name

Jacobson Mark L.

Title

Chief Operating Officer

CIK

0001805812

Roles

Officer

Transaction Details

Transaction Date

2025-09-16

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

40,000

Footnotes

Represents the sale of underlying shares of previously exercised stock options. | Such transaction was pursuant to a pre-approved 10b5-1 plan. | Necessary exercise of stock options set to expire due to attainment of the 10-year expiration date of such options. | Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options. | Represents the sale price of all shares in an open market transaction. | Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $112.93 and $116.87.

Filing Info

Accession No.

0001193125-25-206494

Form Type

4

Issuer CIK

0001579428

Jacobson Mark L.'s History

Date Ticker Type Value
2026-04-21 AXSM A $0
2026-02-26 AXSM M $101K
2026-02-26 AXSM $5.7M
2026-02-26 AXSM M $0
2026-02-26 AXSM A $0
2025-09-22 AXSM M $28K
2025-09-22 AXSM $1.2M
2025-09-22 AXSM M $0
2025-09-16 AXSM $672K
2025-09-16 AXSM M $124K

Other Insiders at AXSM (90d)

Insider Bought Sold Last
TABUTEAU HERRIOT
Chief Executive Officer
$6.0M 2026-04-21
Coleman Mark $4.0M 2026-02-26
Pizzie Nick
Chief Financial Officer
2026-04-21
Jacobson Mark L.
Chief Operating Officer
$5.7M 2026-04-21
Murdock Hunter R.
General Counsel
2026-04-21
Maizel Ari
Chief Commercial Officer
$1.4M 2026-04-22